Video: Every Case Tells a Story| Webinar: ACR/CHEST ILD Guidelines in Practice

An official publication of the ACR and the ARP serving rheumatologists and rheumatology professionals

  • Conditions
    • Axial Spondyloarthritis
    • Gout and Crystalline Arthritis
    • Myositis
    • Osteoarthritis and Bone Disorders
    • Pain Syndromes
    • Pediatric Conditions
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Sjögren’s Disease
    • Systemic Lupus Erythematosus
    • Systemic Sclerosis
    • Vasculitis
    • Other Rheumatic Conditions
  • FocusRheum
    • ANCA-Associated Vasculitis
    • Axial Spondyloarthritis
    • Gout
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Systemic Lupus Erythematosus
  • Guidance
    • Clinical Criteria/Guidelines
    • Ethics
    • Legal Updates
    • Legislation & Advocacy
    • Meeting Reports
      • ACR Convergence
      • Other ACR meetings
      • EULAR/Other
    • Research Rheum
  • Drug Updates
    • Analgesics
    • Biologics/DMARDs
  • Practice Support
    • Billing/Coding
    • EMRs
    • Facility
    • Insurance
    • QA/QI
    • Technology
    • Workforce
  • Opinion
    • Patient Perspective
    • Profiles
    • Rheuminations
      • Video
    • Speak Out Rheum
  • Career
    • ACR ExamRheum
    • Awards
    • Career Development
  • ACR
    • ACR Home
    • ACR Convergence
    • ACR Guidelines
    • Journals
      • ACR Open Rheumatology
      • Arthritis & Rheumatology
      • Arthritis Care & Research
    • From the College
    • Events/CME
    • President’s Perspective
  • Search

Please Hear Me: How Effective Provider-Patient Communication Improved My Psoriatic Arthritis

Ashley Krivohlavek  |  November 29, 2022

PHILADELPHIA—“At age 12, I was diagnosed with psoriasis (PsO), followed by a diagnosis of psoriatic arthritis (PsA) at age 30,” said Ashley Krivohlavek of Oklahoma City in a poster presentation at ACR Convergence 2022. “I’m now 38.”

Please Hear Me: How Effective Provider-Patient Communication Improved My Psoriatic Arthritis

Please Hear Me: How Effective Provider-Patient Communication Improved My Psoriatic Arthritis

 

ad goes here:advert-1
ADVERTISEMENT
SCROLL TO CONTINUE

Ms. Krivohlavek’s Story

In 2020, I had been on an infused biologic for 18 months, but my dose was wearing off between infusions. My disease activity was worsening, and my CRP kept going up. My rheumatologist recommended an injectable. I started the new medication in spring; by summer I was miserable. I had pain, swelling, fatigue and brain fog. This meant I was unable to do basic activities like laundry, cooking or even walking.

At the end of August, I asked my provider for a new medication. I was met with no sense of collaboration. She said there was no reason for my worsening symptoms and that it may be fibromyalgia. I left that appointment feeling dismayed by the lack of collaboration and hopeless at the prospect of managing an added diagnosis.

ad goes here:advert-2
ADVERTISEMENT
SCROLL TO CONTINUE

I started researching. I Googled medical studies and articles about PsA with fibromyalgia and medications. I discovered that PsA and fibromyalgia are comorbidities and that switching biologics can cause flares. What I was experiencing aligned with symptoms of uncontrolled PsA with a few overlapping fibromyalgia symptoms.

I also looked for other rheumatologists. I consulted with the dean of rheumatology at my state university who confirmed that I was not a candidate for fibromyalgia. My symptoms were likely due to uncontrolled PsA. She gave me the name of another rheumatologist, who also confirmed the same.

In a rheumatology desert, with few options, I thought I might have to travel out of state. Fortunately, I stumbled on a practice new to my area that employed nurse practitioners with rheumatology specialization and made an appointment. The first thing my new provider said was that she expected me to be a collaborator in my health journey. I was the captain of my ship, and she was there to support me. She read my notes prior to our visit and ordered extensive labs. We scheduled a follow-up to review my labs and discuss next steps. I felt understood and hopeful.

Since 2021, my health has improved. Gone is the constant fatigue and brain fog and aching swollen joints. My CRP levels are lower than they’ve been since my PsA diagnosis.

My life has become my own again. I re-started graduate school and have been volunteering in health advocacy in my state. The time and effort that goes into having a chronic illness has also become less burdensome: I don’t need to travel to doctor’s appointments as often and I spend less time on the phone with my doctor’s office and insurance company.

This has all been possible because of the collaborative relationship I now have with my rheumatology provider. I communicate with my provider about my needs and PsA goals and she listens and provides constructive feedback. To maintain our collaborative relationship, I wrote up patient communication principles based on my experience (Table 1 in the poster). If I need to change my provider again in the future, I know I can do so with confidence using my Guide to Changing Providers (Figure 1 in the poster).


Ashley Krivohlavek is an Oklahoma native and proud member of the Cherokee Nation. She graduated from the University of Oklahoma with a Master of Arts in 2013. After graduation, she went to work for her family’s business. In 2014, she was diagnosed with psoriatic arthritis.

Share: 

Filed under:ACR ConvergenceAxial SpondyloarthritisConditionsMeeting ReportsOpinionPatient PerspectivePsoriatic ArthritisSpeak Out Rheum Tagged with:ACR Convergence 2022ACR Convergence 2022 – PsApatient perspectivesPsoriatic Arthritis

Related Articles

    The Heterogeneity of Psoriatic Arthritis

    November 21, 2023

    SAN DIEGO—Differences between psoriatic arthritis and rheumatoid arthritis highlight the need for the development of imaging modalities, laboratory tests and other biomarkers that are explored and validated specifically for PsA to advance the goal of personalized or precision medicine. In this article, expert David S. Pisetsky, MD, PhD, explores the top research in psoriatic arthritis presented at ACR Convergence 2023.

    Psoriatic Arthritis: Advances in Therapeutics, Imaging & More Presented at ACR Convergence 2022

    December 1, 2022

    PHILADELPHIA—Selecting my top 10 picks for abstracts in psoriatic arthritis (PsA) at the ACR Convergence 2022 meeting was not easy because there was a great deal to review and learn from the 139 abstracts submitted to the meeting. I focused first and foremost on advances in therapeutics that encompassed both new and approved therapeutics, novel…

    Revising Fibromyalgia: One Year Later

    July 12, 2011

    The 2010 ACR fibromyalgia criteria capture the broader clinical picture and help ensure more appropriate diagnosis and management by primary care

    Case Report: A Psoriatic Arthritis Patient with Dactylitis & Enthesitis

    September 20, 2018

    A 36-year-old woman presented at the Johns Hopkins Arthritis Center for a second opinion regarding a diagnosis of psoriatic arthritis (PsA). One year prior to our evaluation, she had developed pain and stiffness in her hands, feet, knees, ankles, elbows and shoulders. She had mild plaque psoriasis of the scalp and base of the neck,…

  • About Us
  • Meet the Editors
  • Issue Archives
  • Contribute
  • Advertise
  • Contact Us
  • Copyright © 2025 by John Wiley & Sons, Inc. All rights reserved, including rights for text and data mining and training of artificial technologies or similar technologies. ISSN 1931-3268 (print). ISSN 1931-3209 (online).
  • DEI Statement
  • Privacy Policy
  • Terms of Use
  • Cookie Preferences